| Imiquimod studied in …STUDIED_INderived114 of 114show fewer |
|---|
| → studied in | NCT05212246Phase 3 · not yet recruiting Basal Cell Carcinoma Chemoprevention Trial · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00799110Phase 2 · terminated Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod · 114 trials list this drug (8 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07679841Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients · 114 trials list this drug (8 active) | — | — | Vulvar Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03872947Phase 1 · active not recruiting A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors · 114 trials list this drug (8 active) | — | — | Solid Neoplasm,Melanoma,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02600949Phase 1 · enrolling by invitation Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer · 114 trials list this drug (8 active) | — | — | Colorectal Neoplasm,Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838599early Phase 1 · recruiting Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides · 114 trials list this drug (8 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03276832early Phase 1 · completed Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma · 114 trials list this drug (8 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07210775Phase 1/Phase 2 · recruiting Topical Imiquimod Treatment of Oral Dysplasia · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01795313Phase 1 · terminated Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod · 114 trials list this drug (8 active) | — | — | Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03534947Phase 2 · completed A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Malignant Skin Neoplasm,Basal Cell Carcinoma,Invasive Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07251413Phase 1/Phase 2 · recruiting Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Skin Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059499Phase 3 · completed Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions · 114 trials list this drug (8 active) | — | — | Anal Intraepithelial Neoplasia,High Grade Squamous Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03196180early Phase 1 · completed Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia · 114 trials list this drug (8 active) | — | — | High Grade Cervical Intraepithelial Neoplasia,Cervical Intraepithelial Neoplasia Grade 2/3,Cervical Squamous Intraepithelial Neoplasia 2+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01926496Phase 4 · completed Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02078648Phase 1/Phase 2 · completed Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme · 114 trials list this drug (8 active) | — | — | Glioblastoma,Adult Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04883645early Phase 1 · completed Neoadjuvant Imiquimod Immunotherapy for Oral Cancer · 114 trials list this drug (8 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04809662terminated Comparing Immune Responses to Topical Imiquimod · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135419Phase 3 · completed Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions · 114 trials list this drug (8 active) | — | — | High Grade Squamous Intraepithelial Neoplasia,Malignant Anal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01803152Phase 1 · completed Dendritic Cell Vaccine for Children and Adults With Sarcoma · 114 trials list this drug (8 active) | — | — | Sarcoma,Bone Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02394132Phase 3 · completed Radiotherapy or Imiquimod in Complex Lentigo Maligna · 114 trials list this drug (8 active) | — | — | Lentigo Maligna | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02864147Phase 2 · completed Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06252857unknown Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05405270recruiting Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia,Cervical Intraepithelial Neoplasia Grade 2/3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788164Phase 1 · completed Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia · 114 trials list this drug (8 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03180684Phase 2 · completed Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) · 114 trials list this drug (8 active) | — | — | Vulvar Intraepithelial Neoplasia,High Grade Vulvar Squamous Intraepithelial Lesion | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00314756Phase 4 · completed Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05740969Phase 2 · unknown Gene and Protein Expression Profiles After Treatment of Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02802943Phase 2 · completed iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL · 114 trials list this drug (8 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00142454Phase 1 · completed NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting) · 114 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01808820Phase 1 · completed Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma · 114 trials list this drug (8 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Malignant Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189280Phase 3 · completed Aldara for the Treatment of Large and/or Multiple sBCC · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189241Phase 3 · completed A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189254completed A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189267Phase 2 · completed A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189293Phase 4 · completed Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts · 114 trials list this drug (8 active) | — | — | Condyloma Acuminatum | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00294320Phase 3 · completed Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00761371Phase 4 · completed Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777127Phase 4 · completed Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01453179Phase 4 · completed Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04842422Phase 4 · completed Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01421017Phase 1/Phase 2 · completed Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases · 114 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03982004Phase 1 · terminated Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer · 114 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04859361NA · unknown Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301494NA · withdrawn Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma · 114 trials list this drug (8 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861535Phase 3 · completed Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia · 114 trials list this drug (8 active) | — | — | Vulvar Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233412Phase 2 · completed Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions · 114 trials list this drug (8 active) | — | — | High Grade Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914417Phase 2 · completed Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02482428Phase 2 · completed Efficacy and Tolerability of Topical LFX453 for External Genital Warts · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01686152Phase 3 · completed Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289260Phase 3 · unknown Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00948428Phase 3 · completed Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072900Phase 1 · unknown A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma · 114 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02224599Phase 1/Phase 2 · terminated Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies · 114 trials list this drug (8 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118313Phase 1 · completed Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma · 114 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01400672Phase 1 · terminated Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma · 114 trials list this drug (8 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678352early Phase 1 · completed Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02385188Phase 3 · completed Topical 5% Imiquimod Cream for Vulvar Paget's Disease · 114 trials list this drug (8 active) | — | — | Extramammary Paget Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02120898Phase 3 · completed A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362152completed The Real Life Topical Field Treatment of Actinic Keratosis Study · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02276300Phase 1 · completed HER2-Peptide Vaccination of Patients With Solid Tumors · 114 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088737Phase 2/Phase 3 · unknown Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna · 114 trials list this drug (8 active) | — | — | Lentigo Maligna | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03116659early Phase 1 · unknown CTCL Directed Therapy · 114 trials list this drug (8 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234921Phase 1 · completed Pilot Study of DRibble Vaccine for Prostate Cancer Patients · 114 trials list this drug (8 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02917746NA · unknown Imiquimod Treatment of High-grade CIN · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02329171Phase 3 · terminated Imiquimod Treatment of CIN Lesions · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00988559Phase 1 · completed Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504023NA · completed Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva · 114 trials list this drug (8 active) | — | — | Malignant Vulvar Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979550Phase 2 · terminated The Effects of Aldara as an Adjunct to Laser Treatment · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02669459Phase 3 · unknown Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821964Phase 2 · completed Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer · 114 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01171469Phase 1 · completed Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor · 114 trials list this drug (8 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02281682Phase 4 · unknown IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01538901Phase 4 · terminated Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02452307Phase 1/Phase 2 · unknown Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy · 114 trials list this drug (8 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01909752Phase 2 · completed Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer · 114 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02130323Phase 2/Phase 3 · completed Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00596336Phase 2 · terminated Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients · 114 trials list this drug (8 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00865644Phase 1 · completed Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01264731Phase 1 · completed Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma · 114 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689726Phase 1 · terminated Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00774787Phase 4 · completed Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01283763Phase 3 · terminated Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia · 114 trials list this drug (8 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031759Phase 2 · completed Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia · 114 trials list this drug (8 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899574Phase 2 · completed Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases · 114 trials list this drug (8 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00941811Phase 2 · completed Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453050Phase 1 · completed Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin · 114 trials list this drug (8 active) | — | — | Malignant Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01203878Phase 4 · terminated Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403285Phase 1 · terminated Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma · 114 trials list this drug (8 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01788007Phase 1 · completed Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis. · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066872Phase 3 · completed Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707174NA · completed Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna · 114 trials list this drug (8 active) | — | — | Malignant Neoplasm,Lentigo Maligna | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01611480Phase 2 · completed Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079300Phase 1 · completed Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413763Phase 4 · unknown Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00273910Phase 2 · completed Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma · 114 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01161888Phase 4 · completed Effect of Topical Imiquimod on Lentigo Maligna · 114 trials list this drug (8 active) | — | — | Lentigo Maligna | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00803907Phase 4 · unknown Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502020NA · completed A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00204555Phase 4 · completed Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00735462Phase 3 · completed Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts · 114 trials list this drug (8 active) | — | — | Condyloma Acuminatum | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00674739Phase 3 · completed Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts · 114 trials list this drug (8 active) | — | — | Condyloma Acuminatum | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00894647Phase 3 · completed Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00189306Phase 3 · completed Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream · 114 trials list this drug (8 active) | — | — | Superficial Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335179Phase 2 · completed Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116649Phase 4 · completed Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00129519Phase 3 · completed A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00603798Phase 3 · completed Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00605176Phase 3 · completed Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00384124Phase 2/Phase 3 · unknown Topical Imiquimod for Bowen's Disease of the Head and Neck · 114 trials list this drug (8 active) | — | — | Squamous Cell Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601016Phase 2 · completed A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy · 114 trials list this drug (8 active) | — | — | Capillary Hemangioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00463359NA · unknown A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base · 114 trials list this drug (8 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114023completed 1-Year Follow up to the 1473-IMIQ Study · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00115154Phase 4 · completed Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00175643Phase 3 · completed Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses · 114 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |